FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo.
Cejka D, Kuntner C, Preusser M, Fritzer-Szekeres M, Fueger BJ, Strommer S, Werzowa J, Fuereder T, Wanek T, Zsebedics M, Mueller M, Langer O, Wacheck V.
Cejka D, et al. Among authors: strommer s.
Br J Cancer. 2009 Jun 2;100(11):1739-45. doi: 10.1038/sj.bjc.6605076. Epub 2009 May 12.
Br J Cancer. 2009.
PMID: 19436299
Free PMC article.